Although the anti-cancer drug sensitivity of solid tumor cells was increased by FNIII14 in the present study (Fig 1 and Table 1), as is the case in AML cells, the enhanced chemosensitivity observed was accompanied by activation of pro-apoptotic Bim signaling (Figs 2, 3 and S3). The gene discussed is BCL2L11; the disease is cancer.